New blood test may better predict gestational diabetes

[Northerner]

A new study led by researchers at Brigham and Women's Hospital has found that a single measurement of plasma glycated CD59 (GCD59), a novel biomarker for diabetes, at weeks 24-28 of gestation identified, with high sensitivity and specificity, women who failed the glucose challenge test as well as women with gestational diabetes. Plasma levels of GCD59 were also associated with the probability of delivering a large-for-gestational-age newborn. These findings are published in Diabetes Care.

https://www.sciencedaily.com/releases/2017/04/170427112144.htm

 

[mikeyB]

Anything that spares pregnant women a full glucose tolerance test must be a good thing. GTTs are really horrible.